Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385186618> ?p ?o ?g. }
- W4385186618 endingPage "3347" @default.
- W4385186618 startingPage "3337" @default.
- W4385186618 abstract "Abstract Background Immune-related adverse events (irAEs) are frequently encountered by patients during immune checkpoint inhibitor (ICI) treatment and are associated with better treatment outcomes. The sequencing of radiotherapy (RT) and ICIs is widely used in current clinical practice, but its effect on survival has remained unclear. Methods In a real-world multicenter study including 521 patients who received ICI treatment for metastatic or locally advanced cancer, RT schedules and timing, irAEs, time to progression, overall survival, and treatment responses were retrospectively reviewed. Results Patients who received previous RT and developed irAE (RT +/AE +) had the best overall response rate (ORR 44.0%). The ORR was 40.1% in the RT −/AE + group, 26.7% in the RT −/AE − group and 18.3% in the RT + /AE − group ( p < 0.001). There was a significantly longer time to progression (TTP) in the RT + /AE + group compared to the RT −/AE − and RT + /AE − groups (log rank p = 0.001 and p < 0.001, respectively), but the trend toward longer TTP in the RT + /AE + group did not reach statistical significance in pairwise comparison to that in the RT −/AE + group. Preceding RT timing and intent had no statistically significant effect on TTP. In a multivariate model, ECOG = 0 and occurrence of irAEs remained independent positive prognostic factors for TTP (HR 0.737; 95% CI 0.582–0.935; p = 0.012, and HR 0.620; 95% CI 0.499–0.769; p < 0.001, respectively). Conclusions Better ORR and a trend toward longer TTP were demonstrated for patients with RT preceding ICI treatment and development of irAEs, which suggests that RT may boost the therapeutic effect of immunotherapy in patients with metastatic cancers." @default.
- W4385186618 created "2023-07-25" @default.
- W4385186618 creator A5016335631 @default.
- W4385186618 creator A5019774051 @default.
- W4385186618 creator A5020861655 @default.
- W4385186618 creator A5022918041 @default.
- W4385186618 creator A5025050624 @default.
- W4385186618 creator A5027845847 @default.
- W4385186618 creator A5029186353 @default.
- W4385186618 creator A5031945703 @default.
- W4385186618 creator A5032361101 @default.
- W4385186618 creator A5033212128 @default.
- W4385186618 creator A5035791445 @default.
- W4385186618 creator A5037884512 @default.
- W4385186618 creator A5039187209 @default.
- W4385186618 creator A5042344494 @default.
- W4385186618 creator A5043581282 @default.
- W4385186618 creator A5046452137 @default.
- W4385186618 creator A5047154150 @default.
- W4385186618 creator A5060780550 @default.
- W4385186618 creator A5069933334 @default.
- W4385186618 creator A5071945736 @default.
- W4385186618 creator A5082635201 @default.
- W4385186618 date "2023-07-24" @default.
- W4385186618 modified "2023-09-30" @default.
- W4385186618 title "Previous radiotherapy improves treatment responses and causes a trend toward longer time to progression among patients with immune checkpoint inhibitor-related adverse events" @default.
- W4385186618 cites W1999020268 @default.
- W4385186618 cites W2019607817 @default.
- W4385186618 cites W2032166347 @default.
- W4385186618 cites W2127733313 @default.
- W4385186618 cites W2155033435 @default.
- W4385186618 cites W2277326116 @default.
- W4385186618 cites W2461739654 @default.
- W4385186618 cites W2521278016 @default.
- W4385186618 cites W2560367415 @default.
- W4385186618 cites W2572174216 @default.
- W4385186618 cites W2618641368 @default.
- W4385186618 cites W2753065806 @default.
- W4385186618 cites W2754843476 @default.
- W4385186618 cites W2887577080 @default.
- W4385186618 cites W2963686803 @default.
- W4385186618 cites W3093708469 @default.
- W4385186618 cites W3107738233 @default.
- W4385186618 cites W3108819942 @default.
- W4385186618 cites W3119361724 @default.
- W4385186618 cites W3127221517 @default.
- W4385186618 cites W3147500389 @default.
- W4385186618 cites W4226175083 @default.
- W4385186618 doi "https://doi.org/10.1007/s00262-023-03494-4" @default.
- W4385186618 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37486396" @default.
- W4385186618 hasPublicationYear "2023" @default.
- W4385186618 type Work @default.
- W4385186618 citedByCount "0" @default.
- W4385186618 crossrefType "journal-article" @default.
- W4385186618 hasAuthorship W4385186618A5016335631 @default.
- W4385186618 hasAuthorship W4385186618A5019774051 @default.
- W4385186618 hasAuthorship W4385186618A5020861655 @default.
- W4385186618 hasAuthorship W4385186618A5022918041 @default.
- W4385186618 hasAuthorship W4385186618A5025050624 @default.
- W4385186618 hasAuthorship W4385186618A5027845847 @default.
- W4385186618 hasAuthorship W4385186618A5029186353 @default.
- W4385186618 hasAuthorship W4385186618A5031945703 @default.
- W4385186618 hasAuthorship W4385186618A5032361101 @default.
- W4385186618 hasAuthorship W4385186618A5033212128 @default.
- W4385186618 hasAuthorship W4385186618A5035791445 @default.
- W4385186618 hasAuthorship W4385186618A5037884512 @default.
- W4385186618 hasAuthorship W4385186618A5039187209 @default.
- W4385186618 hasAuthorship W4385186618A5042344494 @default.
- W4385186618 hasAuthorship W4385186618A5043581282 @default.
- W4385186618 hasAuthorship W4385186618A5046452137 @default.
- W4385186618 hasAuthorship W4385186618A5047154150 @default.
- W4385186618 hasAuthorship W4385186618A5060780550 @default.
- W4385186618 hasAuthorship W4385186618A5069933334 @default.
- W4385186618 hasAuthorship W4385186618A5071945736 @default.
- W4385186618 hasAuthorship W4385186618A5082635201 @default.
- W4385186618 hasBestOaLocation W43851866181 @default.
- W4385186618 hasConcept C126322002 @default.
- W4385186618 hasConcept C143998085 @default.
- W4385186618 hasConcept C197934379 @default.
- W4385186618 hasConcept C203014093 @default.
- W4385186618 hasConcept C38180746 @default.
- W4385186618 hasConcept C509974204 @default.
- W4385186618 hasConcept C65409693 @default.
- W4385186618 hasConcept C71924100 @default.
- W4385186618 hasConcept C8891405 @default.
- W4385186618 hasConcept C90924648 @default.
- W4385186618 hasConceptScore W4385186618C126322002 @default.
- W4385186618 hasConceptScore W4385186618C143998085 @default.
- W4385186618 hasConceptScore W4385186618C197934379 @default.
- W4385186618 hasConceptScore W4385186618C203014093 @default.
- W4385186618 hasConceptScore W4385186618C38180746 @default.
- W4385186618 hasConceptScore W4385186618C509974204 @default.
- W4385186618 hasConceptScore W4385186618C65409693 @default.
- W4385186618 hasConceptScore W4385186618C71924100 @default.
- W4385186618 hasConceptScore W4385186618C8891405 @default.
- W4385186618 hasConceptScore W4385186618C90924648 @default.
- W4385186618 hasIssue "10" @default.
- W4385186618 hasLocation W43851866181 @default.